According to some experts 2015 could be an important year ever to fight
Alzheimer's disease. The Boston University Alzheimer's Disease Center and
Boston Medical Center will be involved in several studies, together with the
test to observe the effects of a drug known as T-817MA.
At present, just five drugs are approved to treat Alzheimer's disease.
T-817MA is aimed at people who are already suffering from a degree of dementia,
and it could probably change the course of Alzheimer's disease.
"In all the studies that are going on, this is one of the most, if not
the most promising approach to try to slow down the disease in someone who is
already at the point of having moderate stages of dementia," said Dr. Robert
Stern, Director of the Alzheimer's Disease Center.
T-817MA could also help protect brain cells from destruction of Alzheimer's
disease, which causes dementia, Stern added. "The changes in the brain in
Alzheimer's disease begin probably 20 years prior to the first symptoms and
then get worse as the disease further progresses," the doctor said.